Rachel Mitlo

For nearly two decades, MMIT has been solely focused on solving the “what and why” of drug coverage and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn’t face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions. Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry. All legitimate job openings with MMIT will be posted on Norstella’s job board, located at norstella.com/careers. If a role is not posted on this job board, a candidate should assume the role is not a legitimate role with MMIT. MMIT is not responsible for an application submitted by or through a third party. Candidates should proceed with extreme caution if a third party approaches them about an open role with MMIT. MMIT will never request anything of value or payment during or as part of any recruitment, interview, or pre-hire onboarding process. If you are aware of or have reason to believe a job posting purportedly for a role with MMIT is fraudulent or otherwise not authorized by MMIT, please contact the Company using the following email address: [email protected].